Post FDA approves Eli Lilly’s Baqsimi, the first treatment for severe hypoglycemia that can be administered without an injection In this week's post we discuss the approval of Baqsimi nasal powder. This is the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.